Start SIP in AJOONI
Start SIPPerformance
- Low
- ₹7
- High
- ₹7
- 52 Week Low
- ₹4
- 52 Week High
- ₹10
- Open Price₹7
- Previous Close₹7
- Volume382,137
Investment Returns
- Over 1 Month -3.08%
- Over 3 Month -17.09%
- Over 6 Month + 43.45%
- Over 1 Year + 32.18%
Smart Investing Starts Here Start SIP with Ajooni Biotech for Steady Growth!
Ajooni Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 51.1
- PEG Ratio
- 0.8
- Market Cap Cr
- 125
- P/B Ratio
- 2.9
- Average True Range
- 0.34
- EPS
- 0.14
- Dividend Yield
- 0
- MACD Signal
- -0.04
- RSI
- 34.5
- MFI
- 23.53
Ajooni Biotech Financials
Ajooni Biotech Technicals
EMA & SMA
Current Price
₹7.23
-0.1
(-1.36%)
- Bullish Moving Average 2
- Bearish Moving Average 14
- 20 Day
- ₹7.64
- 50 Day
- ₹7.76
- 100 Day
- ₹7.63
- 200 Day
- ₹7.08
Resistance and Support
7.27
- R3 7.75
- R2 7.60
- R1 7.42
- S1 7.09
- S2 6.94
- S3 6.76
Ajooni Biotech Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-13 | Quarterly Results | |
2024-08-16 | Others | To consider other business matters issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-. |
2024-08-09 | Quarterly Results | |
2024-05-20 | Audited Results | |
2024-02-07 | Quarterly Results & Others | Other business matters. issue of equity shares of Rs. 2/- in the ratio of 1:1 @ premium of Rs. 3/-. |
Ajooni Biotech F&O
About Ajooni Biotech
- NSE Symbol
- AJOONI
- BSE Symbol
- Managing Director & CFO
- Mr. Jasjot Singh
- ISIN
- INE820Y01021
Similar Stocks to Ajooni Biotech
Ajooni Biotech FAQs
Ajooni Biotech share price is ₹7 As on 21 December, 2024 | 17:37
The Market Cap of Ajooni Biotech is ₹124.5 Cr As on 21 December, 2024 | 17:37
The P/E ratio of Ajooni Biotech is 51.1 As on 21 December, 2024 | 17:37
The PB ratio of Ajooni Biotech is 2.9 As on 21 December, 2024 | 17:37
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.